That's where GLP-1 treatments come in
A new Nature paper suggests common variants in GLP1R and GIPR influence weight loss and nausea or vomiting, but the effects are modest, and non-genetic factors such as drug choice, dose, duration, sex, diabetes status, and tolerability still matter greatly
86 Despite its potential, further large randomized trials with robust statistical power are needed
Klarity Health is a telehealth platform with **2,000+ licensed providers** who specialize in conditions including weight loss
This rate of weight regain is significantly faster than that seen in those who have lost weight by changing other lifestyle factors, such as diet and exercise, rather than relying on GLP-1 medications, researchers from the University of Oxford report in a paper published Wednesday in The BMJ journal